Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
- PMID: 35456990
- PMCID: PMC9025270
- DOI: 10.3390/ijms23084170
Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
Abstract
The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for new options for both causal treatment and mitigation of its symptoms. Scientists and researchers around the world are constantly looking for the best therapeutic options. These difficult circumstances have also spurred the re-examination of the potential of natural substances contained in Cannabis sativa L. Cannabinoids, apart from CB1 and CB2 receptors, may act multifacetedly through a number of other receptors, such as the GPR55, TRPV1, PPARs, 5-HT1A, adenosine and glycine receptors. The complex anti-inflammatory and antiviral effects of cannabinoids have been confirmed by interactions with various signaling pathways. Considering the fact that the SARS-CoV-2 virus causes excessive immune response and triggers an inflammatory cascade, and that cannabinoids have the ability to regulate these processes, it can be assumed that they have potential to be used in the treatment of COVID-19. During the pandemic, there were many publications on the subject of COVID-19, which indicate the potential impact of cannabinoids not only on the course of the disease, but also their role in prevention. It is worth noting that the anti-inflammatory and antiviral potential are shown not only by well-known cannabinoids, such as cannabidiol (CBD), but also secondary cannabinoids, such as cannabigerolic acid (CBGA) and terpenes, emphasizing the role of all of the plant's compounds and the entourage effect. This article presents a narrative review of the current knowledge in this area available in the PubMed, Scopus and Web of Science medical databases.
Keywords: CBD; COVID-19; Cannabis sativa; SARS-CoV-2; anti-inflammatory; antiviral; cannabinoids; terpene.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Cannabis as antivirals.J Appl Microbiol. 2023 Jan 23;134(1):lxac036. doi: 10.1093/jambio/lxac036. J Appl Microbiol. 2023. PMID: 36626776 Review.
-
Antiviral activities of hemp cannabinoids.Clin Sci (Lond). 2023 Apr 26;137(8):633-643. doi: 10.1042/CS20220193. Clin Sci (Lond). 2023. PMID: 37083031 Free PMC article.
-
Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review.Rev Bras Enferm. 2022 Mar 7;75Suppl 1(Suppl 1):e20201374. doi: 10.1590/0034-7167-2020-1374. eCollection 2022. Rev Bras Enferm. 2022. PMID: 35262598 Review. English, Portuguese.
-
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review.Molecules. 2021 Nov 28;26(23):7216. doi: 10.3390/molecules26237216. Molecules. 2021. PMID: 34885798 Free PMC article. Review.
-
Cannabinoids Receptors in COVID-19: Perpetrators and Victims.Curr Med Chem. 2023;30(34):3832-3845. doi: 10.2174/0929867329666220829145029. Curr Med Chem. 2023. PMID: 36043749 Review.
Cited by
-
CBD resistant Salmonella strains are susceptible to epsilon 34 phage tailspike protein.Front Med (Lausanne). 2023 Mar 7;10:1075698. doi: 10.3389/fmed.2023.1075698. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36960333 Free PMC article.
-
Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028).Biomedicines. 2022 Dec 7;10(12):3168. doi: 10.3390/biomedicines10123168. Biomedicines. 2022. PMID: 36551926 Free PMC article.
-
The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics.Biomedicines. 2022 Aug 12;10(8):1959. doi: 10.3390/biomedicines10081959. Biomedicines. 2022. PMID: 36009504 Free PMC article. Review.
-
Differences in the Perception of Dietary Supplements between Dietary Supplement/Medicine Users and Non-Users.Nutrients. 2022 Oct 3;14(19):4114. doi: 10.3390/nu14194114. Nutrients. 2022. PMID: 36235766 Free PMC article.
-
The Utilization of Plant-Material-Loaded Vesicular Drug Delivery Systems in the Management of Pulmonary Diseases.Curr Issues Mol Biol. 2023 Dec 12;45(12):9985-10017. doi: 10.3390/cimb45120624. Curr Issues Mol Biol. 2023. PMID: 38132470 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous